Global Implantable Drug-Eluting Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 17-Dec-2019
No. of pages: 106

Description

Scope of the Report:

The worldwide market for Implantable Drug-Eluting Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Implantable Drug-Eluting Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Pfizer

- Boston Scientific Corporation

- Bayer AG

- Medtronic

- Surmodics

- Merck

- BIOTRONIK

- Abbott

- Johnson & Johnson

- Titan Pharmaceuticals, Inc.

- Allergan

- MicroPort Medical

- Bausch & Lomb

- REVA Medical

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Implantable Drug Infusion Pumps

- Intraocular Drug-Eluting Devices

- Contraceptive Drug-Eluting Devices

- Drug-Eluting Stents

- Others

Market Segment by Applications, can be divided into

- Diabetes

- Contraception

- HIV/AIDS Prevention

- Chronic Pain Management

- Cardiovascular

- Ophthalmology

- Oncology

- Others

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Implantable Drug-Eluting Devices product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Implantable Drug-Eluting Devices, with price, sales, revenue and global market share of Implantable Drug-Eluting Devices in 2017 and 2018.

Chapter 3, the Implantable Drug-Eluting Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Implantable Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Implantable Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Implantable Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Implantable Drug-Eluting Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview
1.1 Implantable Drug-Eluting Devices Introduction
1.2 Market Analysis by Type
1.2.1 Implantable Drug Infusion Pumps
1.2.2 Intraocular Drug-Eluting Devices
1.2.3 Contraceptive Drug-Eluting Devices
1.2.4 Drug-Eluting Stents
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Diabetes
1.3.2 Contraception
1.3.3 HIV/AIDS Prevention
1.3.4 Chronic Pain Management
1.3.5 Cardiovascular
1.3.6 Ophthalmology
1.3.7 Oncology
1.3.8 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Implantable Drug-Eluting Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Boston Scientific Corporation
2.2.1 Business Overview
2.2.2 Implantable Drug-Eluting Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer AG
2.3.1 Business Overview
2.3.2 Implantable Drug-Eluting Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer AG Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Medtronic
2.4.1 Business Overview
2.4.2 Implantable Drug-Eluting Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Medtronic Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Surmodics
2.5.1 Business Overview
2.5.2 Implantable Drug-Eluting Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Surmodics Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Merck
2.6.1 Business Overview
2.6.2 Implantable Drug-Eluting Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 BIOTRONIK
2.7.1 Business Overview
2.7.2 Implantable Drug-Eluting Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Abbott
2.8.1 Business Overview
2.8.2 Implantable Drug-Eluting Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Abbott Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.2 Implantable Drug-Eluting Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Titan Pharmaceuticals, Inc.
2.10.1 Business Overview
2.10.2 Implantable Drug-Eluting Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Allergan
2.11.1 Business Overview
2.11.2 Implantable Drug-Eluting Devices Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Allergan Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 MicroPort Medical
2.12.1 Business Overview
2.12.2 Implantable Drug-Eluting Devices Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 MicroPort Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Bausch & Lomb
2.13.1 Business Overview
2.13.2 Implantable Drug-Eluting Devices Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 REVA Medical
2.14.1 Business Overview
2.14.2 Implantable Drug-Eluting Devices Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 REVA Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Implantable Drug-Eluting Devices Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Implantable Drug-Eluting Devices Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Implantable Drug-Eluting Devices Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Implantable Drug-Eluting Devices Manufacturer Market Share in 2018
3.3.2 Top 6 Implantable Drug-Eluting Devices Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Implantable Drug-Eluting Devices Market Analysis by Regions
4.1 Global Implantable Drug-Eluting Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Implantable Drug-Eluting Devices Sales and Market Share by Regions (2014-2019)
4.1.2 Global Implantable Drug-Eluting Devices Revenue and Market Share by Regions (2014-2019)
4.2 North America Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
4.3 Europe Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
4.5 South America Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
5 North America Implantable Drug-Eluting Devices by Country
5.1 North America Implantable Drug-Eluting Devices Sales, Revenue and Market Share by Country
5.1.1 North America Implantable Drug-Eluting Devices Sales and Market Share by Country (2014-2019)
5.1.2 North America Implantable Drug-Eluting Devices Revenue and Market Share by Country (2014-2019)
5.2 United States Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
5.3 Canada Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
5.4 Mexico Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
6 Europe Implantable Drug-Eluting Devices by Country
6.1 Europe Implantable Drug-Eluting Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Implantable Drug-Eluting Devices Sales and Market Share by Country (2014-2019)
6.1.2 Europe Implantable Drug-Eluting Devices Revenue and Market Share by Country (2014-2019)
6.2 Germany Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
6.3 UK Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
6.4 France Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
6.5 Russia Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
6.6 Italy Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
7 Asia-Pacific Implantable Drug-Eluting Devices by Country
7.1 Asia-Pacific Implantable Drug-Eluting Devices Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Implantable Drug-Eluting Devices Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Implantable Drug-Eluting Devices Revenue and Market Share by Country (2014-2019)
7.2 China Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
7.3 Japan Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
7.4 Korea Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
7.5 India Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
8 South America Implantable Drug-Eluting Devices by Country
8.1 South America Implantable Drug-Eluting Devices Sales, Revenue and Market Share by Country
8.1.1 South America Implantable Drug-Eluting Devices Sales and Market Share by Country (2014-2019)
8.1.2 South America Implantable Drug-Eluting Devices Revenue and Market Share by Country (2014-2019)
8.2 Brazil Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
8.3 Argentina Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
8.4 Colombia Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
9 Middle East and Africa Implantable Drug-Eluting Devices by Countries
9.1 Middle East and Africa Implantable Drug-Eluting Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Implantable Drug-Eluting Devices Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Implantable Drug-Eluting Devices Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
9.3 Turkey Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
9.4 Egypt Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
9.5 Nigeria Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
9.6 South Africa Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
10 Global Implantable Drug-Eluting Devices Market Segment by Type
10.1 Global Implantable Drug-Eluting Devices Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Implantable Drug-Eluting Devices Sales and Market Share by Type (2014-2019)
10.1.2 Global Implantable Drug-Eluting Devices Revenue and Market Share by Type (2014-2019)
10.2 Implantable Drug Infusion Pumps Sales Growth and Price
10.2.1 Global Implantable Drug Infusion Pumps Sales Growth (2014-2019)
10.2.2 Global Implantable Drug Infusion Pumps Price (2014-2019)
10.3 Intraocular Drug-Eluting Devices Sales Growth and Price
10.3.1 Global Intraocular Drug-Eluting Devices Sales Growth (2014-2019)
10.3.2 Global Intraocular Drug-Eluting Devices Price (2014-2019)
10.4 Contraceptive Drug-Eluting Devices Sales Growth and Price
10.4.1 Global Contraceptive Drug-Eluting Devices Sales Growth (2014-2019)
10.4.2 Global Contraceptive Drug-Eluting Devices Price (2014-2019)
10.5 Drug-Eluting Stents Sales Growth and Price
10.5.1 Global Drug-Eluting Stents Sales Growth (2014-2019)
10.5.2 Global Drug-Eluting Stents Price (2014-2019)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2014-2019)
10.6.2 Global Others Price (2014-2019)
11 Global Implantable Drug-Eluting Devices Market Segment by Application
11.1 Global Implantable Drug-Eluting Devices Sales Market Share by Application (2014-2019)
11.2 Diabetes Sales Growth (2014-2019)
11.3 Contraception Sales Growth (2014-2019)
11.4 HIV/AIDS Prevention Sales Growth (2014-2019)
11.5 Chronic Pain Management Sales Growth (2014-2019)
11.6 Cardiovascular Sales Growth (2014-2019)
11.7 Ophthalmology Sales Growth (2014-2019)
11.8 Oncology Sales Growth (2014-2019)
11.9 Others Sales Growth (2014-2019)
12 Implantable Drug-Eluting Devices Market Forecast (2019-2024)
12.1 Global Implantable Drug-Eluting Devices Sales, Revenue and Growth Rate (2019-2024)
12.2 Implantable Drug-Eluting Devices Market Forecast by Regions (2019-2024)
12.2.1 North America Implantable Drug-Eluting Devices Market Forecast (2019-2024)
12.2.2 Europe Implantable Drug-Eluting Devices Market Forecast (2019-2024)
12.2.3 Asia-Pacific Implantable Drug-Eluting Devices Market Forecast (2019-2024)
12.2.4 South America Implantable Drug-Eluting Devices Market Forecast (2019-2024)
12.2.5 Middle East and Africa Implantable Drug-Eluting Devices Market Forecast (2019-2024)
12.3 Implantable Drug-Eluting Devices Market Forecast by Type (2019-2024)
12.3.1 Global Implantable Drug-Eluting Devices Sales Forecast by Type (2019-2024)
12.3.2 Global Implantable Drug-Eluting Devices Market Share Forecast by Type (2019-2024)
12.4 Implantable Drug-Eluting Devices Market Forecast by Application (2019-2024)
12.4.1 Global Implantable Drug-Eluting Devices Sales Forecast by Application (2019-2024)
12.4.2 Global Implantable Drug-Eluting Devices Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Implantable Drug-Eluting Devices Picture
Table Product Specifications of Implantable Drug-Eluting Devices
Figure Global Sales Market Share of Implantable Drug-Eluting Devices by Types in 2018
Table Implantable Drug-Eluting Devices Types for Major Manufacturers
Figure Implantable Drug Infusion Pumps Picture
Figure Intraocular Drug-Eluting Devices Picture
Figure Contraceptive Drug-Eluting Devices Picture
Figure Drug-Eluting Stents Picture
Figure Others Picture
Figure Implantable Drug-Eluting Devices Sales Market Share by Applications in 2018
Figure Diabetes Picture
Figure Contraception Picture
Figure HIV/AIDS Prevention Picture
Figure Chronic Pain Management Picture
Figure Cardiovascular Picture
Figure Ophthalmology Picture
Figure Oncology Picture
Figure Others Picture
Figure United States Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure France Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure UK Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure China Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure India Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Implantable Drug-Eluting Devices Revenue (Value) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Implantable Drug-Eluting Devices Type and Applications
Table Pfizer Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Corporation Implantable Drug-Eluting Devices Type and Applications
Table Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Implantable Drug-Eluting Devices Type and Applications
Table Bayer AG Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Implantable Drug-Eluting Devices Type and Applications
Table Medtronic Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Surmodics Basic Information, Manufacturing Base and Competitors
Table Surmodics Implantable Drug-Eluting Devices Type and Applications
Table Surmodics Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Implantable Drug-Eluting Devices Type and Applications
Table Merck Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BIOTRONIK Basic Information, Manufacturing Base and Competitors
Table BIOTRONIK Implantable Drug-Eluting Devices Type and Applications
Table BIOTRONIK Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Implantable Drug-Eluting Devices Type and Applications
Table Abbott Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Implantable Drug-Eluting Devices Type and Applications
Table Johnson & Johnson Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Titan Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Type and Applications
Table Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Implantable Drug-Eluting Devices Type and Applications
Table Allergan Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table MicroPort Medical Implantable Drug-Eluting Devices Type and Applications
Table MicroPort Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table Bausch & Lomb Implantable Drug-Eluting Devices Type and Applications
Table Bausch & Lomb Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table REVA Medical Basic Information, Manufacturing Base and Competitors
Table REVA Medical Implantable Drug-Eluting Devices Type and Applications
Table REVA Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Implantable Drug-Eluting Devices Sales by Manufacturer (2017-2018)
Figure Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturer in 2017
Figure Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturer in 2018
Table Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2017-2018)
Figure Global Implantable Drug-Eluting Devices Revenue Market Share by Manufacturer in 2017
Figure Global Implantable Drug-Eluting Devices Revenue Market Share by Manufacturer in 2018
Figure Top 3 Implantable Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Implantable Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2018
Figure Global Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Global Implantable Drug-Eluting Devices Revenue and Growth Rate (2014-2019)
Table Global Implantable Drug-Eluting Devices Sales by Regions (2014-2019)
Table Global Implantable Drug-Eluting Devices Sales Market Share by Regions (2014-2019)
Table Global Implantable Drug-Eluting Devices Revenue by Regions (2014-2019)
Figure Global Implantable Drug-Eluting Devices Revenue Market Share by Regions (2014-2019)
Figure Global Implantable Drug-Eluting Devices Revenue Market Share by Regions in 2018
Figure North America Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Europe Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure South America Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure North America Implantable Drug-Eluting Devices Revenue and Growth Rate (2014-2019)
Table North America Implantable Drug-Eluting Devices Sales by Countries (2014-2019)
Table North America Implantable Drug-Eluting Devices Sales Market Share by Countries (2014-2019)
Figure North America Implantable Drug-Eluting Devices Sales Market Share by Countries (2014-2019)
Figure North America Implantable Drug-Eluting Devices Sales Market Share by Countries in 2018
Table North America Implantable Drug-Eluting Devices Revenue by Countries (2014-2019)
Table North America Implantable Drug-Eluting Devices Revenue Market Share by Countries (2014-2019)
Figure North America Implantable Drug-Eluting Devices Revenue Market Share by Countries (2014-2019)
Figure North America Implantable Drug-Eluting Devices Revenue Market Share by Countries in 2018
Figure United States Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Canada Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Mexico Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Europe Implantable Drug-Eluting Devices Revenue and Growth Rate (2014-2019)
Table Europe Implantable Drug-Eluting Devices Sales by Countries (2014-2019)
Table Europe Implantable Drug-Eluting Devices Sales Market Share by Countries (2014-2019)
Table Europe Implantable Drug-Eluting Devices Revenue by Countries (2014-2019)
Figure Europe Implantable Drug-Eluting Devices Revenue Market Share by Countries (2014-2019)
Figure Europe Implantable Drug-Eluting Devices Revenue Market Share by Countries in 2018
Figure Germany Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure UK Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure France Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Russia Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Italy Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Implantable Drug-Eluting Devices Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Implantable Drug-Eluting Devices Sales by Countries (2014-2019)
Table Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Countries 2018
Table Asia-Pacific Implantable Drug-Eluting Devices Revenue by Countries (2014-2019)
Figure Asia-Pacific Implantable Drug-Eluting Devices Revenue Market Share by Countries 2018
Figure China Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Japan Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Korea Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure India Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Southeast Asia Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure South America Implantable Drug-Eluting Devices Revenue and Growth Rate (2014-2019)
Table South America Implantable Drug-Eluting Devices Sales by Countries (2014-2019)
Table South America Implantable Drug-Eluting Devices Sales Market Share by Countries (2014-2019)
Figure South America Implantable Drug-Eluting Devices Sales Market Share by Countries in 2018
Table South America Implantable Drug-Eluting Devices Revenue by Countries (2014-2019)
Table South America Implantable Drug-Eluting Devices Revenue Market Share by Countries (2014-2019)
Figure South America Implantable Drug-Eluting Devices Revenue Market Share by Countries in 2018
Figure Brazil Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Argentina Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Colombia Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Implantable Drug-Eluting Devices Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Implantable Drug-Eluting Devices Sales by Countries (2014-2019)
Table Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Countries in 2018
Table Middle East and Africa Implantable Drug-Eluting Devices Revenue by Countries (2014-2019)
Table Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Countries in 2018
Figure Saudi Arabia Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure UAE Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Egypt Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure Nigeria Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Figure South Africa Implantable Drug-Eluting Devices Sales and Growth Rate (2014-2019)
Table Global Implantable Drug-Eluting Devices Sales by Type (2014-2019)
Table Global Implantable Drug-Eluting Devices Sales Share by Type (2014-2019)
Table Global Implantable Drug-Eluting Devices Revenue by Type (2014-2019)
Table Global Implantable Drug-Eluting Devices Revenue Share by Type (2014-2019)
Figure Global Implantable Drug Infusion Pumps Sales Growth (2014-2019)
Figure Global Implantable Drug Infusion Pumps Price (2014-2019)
Figure Global Intraocular Drug-Eluting Devices Sales Growth (2014-2019)
Figure Global Intraocular Drug-Eluting Devices Price (2014-2019)
Figure Global Contraceptive Drug-Eluting Devices Sales Growth (2014-2019)
Figure Global Contraceptive Drug-Eluting Devices Price (2014-2019)
Figure Global Drug-Eluting Stents Sales Growth (2014-2019)
Figure Global Drug-Eluting Stents Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Implantable Drug-Eluting Devices Sales by Application (2014-2019)
Table Global Implantable Drug-Eluting Devices Sales Share by Application (2014-2019)
Figure Global Diabetes Sales Growth (2014-2019)
Figure Global Contraception Sales Growth (2014-2019)
Figure Global HIV/AIDS Prevention Sales Growth (2014-2019)
Figure Global Chronic Pain Management Sales Growth (2014-2019)
Figure Global Cardiovascular Sales Growth (2014-2019)
Figure Global Ophthalmology Sales Growth (2014-2019)
Figure Global Oncology Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Implantable Drug-Eluting Devices Sales, Revenue and Growth Rate (2019-2024)
Table Global Implantable Drug-Eluting Devices Sales Forecast by Regions (2019-2024)
Table Global Implantable Drug-Eluting Devices Market Share Forecast by Regions (2019-2024)
Figure North America Sales Implantable Drug-Eluting Devices Market Forecast (2019-2024)
Figure Europe Sales Implantable Drug-Eluting Devices Market Forecast (2019-2024)
Figure Asia-Pacific Sales Implantable Drug-Eluting Devices Market Forecast (2019-2024)
Figure South America Sales Implantable Drug-Eluting Devices Market Forecast (2019-2024)
Figure Middle East and Africa Sales Implantable Drug-Eluting Devices Market Forecast (2019-2024)
Table Global Implantable Drug-Eluting Devices Sales Forecast by Type (2019-2024)
Table Global Implantable Drug-Eluting Devices Market Share Forecast by Type (2019-2024)
Table Global Implantable Drug-Eluting Devices Sales Forecast by Application (2019-2024)
Table Global Implantable Drug-Eluting Devices Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs